Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.

Publish Date : 23-Mar-2015

A majority of patients who get TB for the first time need to be treated with a combination of 4 drugs for 2 months and a combination of 2 drugs for a further 4 months to attain a cure.
Nearly all those who look for private treatment - an estimated 50% of India's TB patients - are prescribed daily drug therapy. However, the TB control programme hands over the pills to its patients three times a week, practising "intermittent therapy".

Health experts have criticized the government for delaying the execution of a proposed daily drug therapy for tuberculosis (TB) patients, that aims to reduce the risk of relapse after the treatment is completed. In 2014, the health ministry had itself introduced TB treatment standards stressing on a move towards daily therapy, almost every patient treated under the government TB control programme receive thrice-a-week therapy, which has a higher risk of relapse. A group of non-government health organisations has urged the Central government to rapidly phase out the thrice-a-week therapy.

The group said the delays in executing the daily regimen shows that the government is giving more priority to logistics and cost than the interests of patients. Access campaign organizer in India with Medecins Sans Frontieres (MSF), the global humanitarian agency, Leena Menghaney, said : "We're asking for something that has been adopted by almost all countries but India. We're wondering when the health ministry will roll this out."

Go to previous page